Data on 566 patients with traumatic brain injuries revealed those who received erythropoiesis-stimulating agents were 75% less likely to die of the condition compared with those not given the red blood cell-producing agents. The findings appear in the journal Archives of Surgery.
Boosting red blood cells is linked to lower brain trauma mortality
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|